The availability of effective therapeutic interventions to promote the acute salvage and subsequent definitive revascularization of jeoparized myocardium after a myocardial infarction has prompted the development of a number of noninvasive techniques for the detection of myocyte viability in this setting. Newly developed noninvasive metabolic probes (positron emission tomography [PET] and nuclear magnetic resonance [NMR] spectroscopy) may supplant available methods of regional ventricular function and perfusion assessment as the definitive techniques for determination of myocardial viability. Myocardial perfusion imaging with Thallium 201 or technetium-labeled isonitriles can be used acutely or in the chronic postinfarction setting to identify areas of residual blood flow. Regional wall motion changes assessed by radionuclide ventriculography or two-dimensional echocardiography may be correlated with perfusion imaging to improve the predictive value of thallium imaging for residual viability. Echocardiography tissue characterization, with or without the use of contrast agents, can be used to define the ischemic risk area and can experimentally distinguish infarcted from potentially viable myocardium. Accumulation of fluorine 18-labeled deoxyglucose and abnormal clearance of C 11-palmitate have been used to identify patients who may benefit from subsequent revascularization procedures. A similar discordance between flow and metabolic tracers is observed with single photon-emitting radionuclides such as iodophenylpentadecanoic acid. Proton NMR imaging is not yet able to distinguish viable from infarcted tissue, and NMR spectroscopy is now performed experimentally to identify changes in oxidative phosphorylation in infarcted and ischemic myocardium. 23NMR imaging following the administration of &dquo;shift&dquo; reagents has been experimentally evaluated for the detection of intracellular edema characteristic of irreversible ischemic injury.After infarction, markers of myocardial viability are less available than are methods for the diagnosis and quantification of myocardial necrosis. The focus of investigation has recently shifted from infarct size as a prognostic and therapeutic end point to the noninvasive determination of the functional and metabolic correlates of myocyte viability.The availability of effective therapeutic interventions to promote acute salvage and subsequent definitive revascularization of jeopardized myocardium after a myocardial infarction has prompted the development of a number of noninvasive techniques for the detection of myocyte viability in this setting. Newly developed noninvasive metabolic probes (e.g., positron emission tomography [PET] and nuclear magnetic resonance [NMR] spectros-